SOVREMENNAYA PEDIATRIYA.2016.3(75):38-40; doi10.15574/SP.2016.75.38 

Principles of effective therapy of bacterial meningitis 

Jafarova K. A.

Department of Infectious Diseases of Azerbaijan Medical University, Baku 

The study of cerebrospinal fluid is essential for effective treatment. The aim of this study was to examine the basic principles of the treatment of bacterial meningitis. IP-adherence included patients received in-patient treatment with the diagnosis of meningitis. Research conducted in the department neuro-communicable diseases №1 Clinical Children's Hospital №2 named A.F.Garaeva, follow Isa-CSF in 25 patients (aged 1 to 10 years) BGM!time personal cause. According to the authors to clarify the etiological factors in BGF is expedient to appoint panampitsillina (polusinte-matic drug penicillin) in high doses. Summarizing the above outlined can come to the conclusion that the effectiveness of those causal therapy, when given their pectoralis complications and course of the disease may be assessed only on the basis of liquorologic research.

Key words: purulent meningitis, pneumococcal meningitis, cerebrospinal fluid.

REFERENCES

1. Vengerov YuYa, Nagibina MV, Migmanov TE et al. 2007. Aktualnyie problemyi diagnostiki i lecheniya bakterialnyih meningitov. Lechaschiy vrach. 9: 31—35.

2. Ivanova MV, Skripchenko NV, Komantsev VN et al. 2007. Aktualnyie problemyi infektsionnyih zabolevaniy nervnoy sistemyi u detey. Pediatriya. 1: 101—113.

3. Beloborodov VB. 2006. Sovremennaya antibakterialnaya terapiya gnoynyih meningitov. Antibiotiki i himioterapiya. 8: 27—34.

4. Ivanova MV, Skripchenko NV, Vilnits AA. 2009. Sovremennyie aspektyi bakterialno-gribkovyih meningitov u detey: klinika i lechenie. Epidemiologiya i infekts bolezni. 6: 42—44.

5. Ivanov IV, Pershin OV, Zinoveva LI et al. 2005. Kliniko-laboratornaya harakteristika bakterialnyih meningitov u detey. Neyroimmunologiya. 3; 2: 139.

6. Sorokina MN, Ivanova VV, Skripchenko NV. 2004. Virusnyie entsefalityi i meningityi u detey. Moskva, Meditsina: 416.

7. Scherbina MA. 2007. Variantyi techeniya generalizovannyih form meningokokkovoy infektsii u detey v mezhepidemicheskiy period. Avtoref dis kand med nauk. Samara: 24.

8. Vermont CL, Hazelzet JA, Kleijn ED et al. 2006. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit Care. 10; 1: 33.

9. Thompson MJ, Ninis N, Perera R et al. 2006. Clinical recognition of meningococcal disease in children and adolescents. The Lancet. 367; 9508: 397—103.

10. Buysse CM, Raat H, Hazelzet JA et al. 2007. Long-term health-related quality of life in survivors of meningococcal septic shock in childhood and their parents. Quality of Life Research. 16; 10: 1567—1576.

11. Harnden A, Ninis N, Thompson M et al. 2006. Parenteral penicillin for children with meningococcal disease before hospital admission: case)control study. Brit Med J. 332; 12: 1295—1298.

12. Tunkel AR, Scheld WM. 2003. Pathogenesis and pathophysiology of bacterial meningitis. Clinical Microbiology Rev. 6; 1: 118—119.